Tocagen’s First-in-Human Clinical Trial Of Toca 511 Enrolling Patients With High Grade Glioma
Tocagen Inc. announced the company is enrolling patients with recurrent high grade glioma, such as those with glioblastoma multiforme (GBM, Grade 4), in its first-in-human clinical trial of Toca 511...